From “Kidneys Govern Bones” to Chronic Kidney Disease, Diabetes Mellitus, and Metabolic Bone Disorder: A Crosstalk between Traditional Chinese Medicine and Modern Science
Open Access
- 1 January 2016
- journal article
- review article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2016 (1) , 4370263
Abstract
Although traditional Chinese medicine (TCM) and Western medicine have evolved on distinct philosophical foundations and reasoning methods, an increasing body of scientific data has begun to reveal commonalities. Emerging scientific evidence has confirmed the validity and identified the molecular mechanisms of many ancient TCM theories. One example is the concept of “Kidneys Govern Bones.” Here we discuss the molecular mechanisms supporting this theory and its potential significance in treating complications of chronic kidney disease (CKD) and diabetes mellitus. Two signaling pathways essential for calcium‐phosphate metabolism can mediate the effect of kidneys in bone homeostasis, one requiring renal production of bioactive vitamin D and the other involving an endocrine axis based on kidney‐expressed Klotho and bone‐secreted fibroblast growth factor 23. Disruption of either pathway can lead to calcium‐phosphate imbalance and vascular calcification, accelerating metabolic bone disorder. Chinese herbal medicine is an adjunct therapy widely used for treating CKD and diabetes. Our results demonstrate the therapeutic effects and underlying mechanisms of a Chinese herbal formulation, Shen‐An extracts, in diabetic nephropathy and renal osteodystrophy. We believe that the smart combination of Eastern and Western concepts holds great promise for inspiring new ideas and therapies for preventing and treating complications of CKD and diabetes.Keywords
Funding Information
- National Natural Science Foundation of China (81573907)
- Natural Science Foundation of Hubei Province (2010CDA033)
This publication has 73 references indexed in Scilit:
- Fibroblast growth factor 23 and soluble klotho in children with chronic kidney diseaseNephrology Dialysis Transplantation, 2012
- Role of Medicinal Plants and Natural Products on Osteoporotic Fracture HealingEvidence-Based Complementary and Alternative Medicine, 2012
- Regulation and Function of the FGF23/Klotho Endocrine PathwaysPhysiological Reviews, 2012
- Klotho deficiency is an early biomarker of renal ischemia–reperfusion injury and its replacement is protectiveKidney International, 2010
- Regulatory mechanisms in vascular calcificationNature Reviews Cardiology, 2010
- Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic ( Hyp ) mouse modelThe FASEB Journal, 2009
- In vivo genetic evidence for klotho‐dependent, fibroblast growth factor 23 (Fgf23) ‐mediated regulation of systemic phosphate homeostasisThe FASEB Journal, 2008
- Klotho converts canonical FGF receptor into a specific receptor for FGF23Nature, 2006
- Suppression of Aging in Mice by the Hormone KlothoScience, 2005
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984